SCHEMBL1837393

SCHEMBL1837393

O=C(Nc1ccccc1Cc1ccccc1NC(=O)Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ RAB9A P51151 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ TRPV1 Q8NER1 1/20 0.51
▸ ALDH1A1 P00352 8/20 0.50
▸ MAPT P10636 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ CYP1A2 P05177 3/20 0.50
▸ THRB P10828 1/20 0.50
▸ GFER P55789 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ RAD51 Q06609 1/20 0.49
▸ GAA P10253 3/20 0.48
▸ HPGD P15428 2/20 0.48
▸ GLA P06280 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ MAOB P27338 1/20 0.48
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1953484 0.85 RAB9A (0.65) KMT2AMEN1RAB9ANPC1NPSR1
SCHEMBL15223404 0.83 ALDH1A1 (0.50) KMT2AMEN1RAB9ANPC1NPSR1
SCHEMBL1841957 0.80 TDP1 (0.44) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL1836106 0.80 L3MBTL1 (0.51) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL1836123 0.79 HTT (0.46) KMT2AMEN1ALDH1A1MAPTGAA
SCHEMBL1641651 0.79 KMT2A (0.55) KMT2AMEN1RAB9ANPC1NPSR1
SCHEMBL8154848 0.79 TRPV1 (0.66) KMT2AMEN1RAB9ANPC1NPSR1
SCHEMBL10489876 0.79 RAB9A (0.50) KMT2AMEN1RAB9ANPC1NPSR1
SCHEMBL1837770 0.79 CHRM3 (0.47) KMT2AMEN1RAB9ANPC1ALDH1A1
SCHEMBL1835368 0.78 L3MBTL1 (0.47) KMT2AMEN1RAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322504-B9 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER ASAHI CHEMICAL IND (JP) 2017-09-06 — — EP disclosed
EP-2322504-B1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER ASAHI CHEMICAL IND (JP) 2016-09-28 — — EP disclosed
US-9249090-B2 N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2016-02-02 — — US disclosed
US-20150038742-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-02-05 — — US disclosed
US-8884047-B2 N-substituted carbamic acid ester production method and isocyanate production method using the N-substituted carbamic acid ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-11-11 — — US disclosed
US-20110160476-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ASAHI KASEI CHEMICALS CORPORATION (JP) 2011-06-30 — — US disclosed
EP-2322504-A1 PROCESS FOR THE PREPARATION OF N-SUBSTITUTED CARBAMIC ACID ESTER AND PROCESS FOR THE PREPARATION OF ISOCYANATE USING THE N-SUBSTITUTED CARBAMIC ACID ESTER Asahi Kasei Chemicals Corporation (JP) 2011-05-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160476-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ALKBH3, CPS1, APEH KMT2A 1122/4885MEN1 1966/4885RAB9A 2751/4885
US-20150038742-A1 N-Substituted Carbamic Acid Ester Production Method and Isocyanate Production Method Using the N-Substituted Carbamic Acid Ester ALKBH3, CPS1, APEH KMT2A 1122/4885MEN1 1966/4885RAB9A 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback